MY183638A - Nucleoside phosphoramidate prodrugs - Google Patents
Nucleoside phosphoramidate prodrugsInfo
- Publication number
- MY183638A MY183638A MYPI2013700238A MYPI2013700238A MY183638A MY 183638 A MY183638 A MY 183638A MY PI2013700238 A MYPI2013700238 A MY PI2013700238A MY PI2013700238 A MYPI2013700238 A MY PI2013700238A MY 183638 A MY183638 A MY 183638A
- Authority
- MY
- Malaysia
- Prior art keywords
- phosphoramidate prodrugs
- nucleoside phosphoramidate
- formula
- treatment
- disclosed
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- -1 Nucleoside phosphoramidate Chemical class 0.000 title 1
- 239000002777 nucleoside Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: [formula I] Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2013700238A MY183638A (en) | 2008-03-26 | 2008-03-26 | Nucleoside phosphoramidate prodrugs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2013700238A MY183638A (en) | 2008-03-26 | 2008-03-26 | Nucleoside phosphoramidate prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY183638A true MY183638A (en) | 2021-03-04 |
Family
ID=82802234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2013700238A MY183638A (en) | 2008-03-26 | 2008-03-26 | Nucleoside phosphoramidate prodrugs |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY183638A (en) |
-
2008
- 2008-03-26 MY MYPI2013700238A patent/MY183638A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014502771A1 (en) | Nucleoside phosphoramidate prodrugs | |
| MX2010013768A (en) | Nucleoside cyclicphosphates. | |
| WO2012142523A3 (en) | 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment | |
| PH12017501426A1 (en) | Derivatives of betulin | |
| NZ593647A (en) | Synthesis of purine nucleosides | |
| PH12014501134A1 (en) | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication | |
| PH12013500035A1 (en) | Methods and compounds for treating paramyxoviridae virus infections | |
| NZ617066A (en) | Nucleoside analogs | |
| PH12012500634A1 (en) | Processes for preparing of glucopyranosyl -substituted benzyl -benzene derivatives | |
| NZ604716A (en) | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds | |
| MD20150036A2 (en) | 2'-Chloro nucleoside analogs for HCV infection | |
| PH12012501650B1 (en) | Heterocyclic compound | |
| PH12015501585A1 (en) | Manufacturing process for pyrimidine derivatives | |
| MX350810B (en) | 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication. | |
| NZ631182A (en) | Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds | |
| IN2014CN04449A (en) | ||
| HK1217295A1 (en) | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives | |
| MX2011006095A (en) | Dihydroetorphines and their preparation. | |
| MX2010009926A (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. | |
| WO2007083243A3 (en) | An improved process for the preparation of risedronate sodium hemi-pentahydrate | |
| MY183716A (en) | Nucleoside phosphoramidate prodrugs | |
| WO2013036846A3 (en) | N4 derivatives of deoxycytidine prodrugs | |
| WO2012150183A8 (en) | Crystalline sodium salt of an hiv integrase inhibitor | |
| WO2008152518A3 (en) | Process for the preparation of risedronic acid or risedronate sodium | |
| GR20110100398A (en) | Process for the preparation of 3-(n-methyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid salt or derivatives thereof |